The ORATOR trial found no significant difference in survival outcomes between radiation therapy and transoral robotic surgery for HPV-related oropharyngeal cancer. Radiation therapy patients ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Authors ...
A new study from researchers at Henry Ford Hospital finds an incisionless robotic surgery - done alone or in conjunction with chemotherapy or radiation - may offer oropharyngeal cancer patients good ...
A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...
Personalized treatment for oropharyngeal cancer is essential, with patient involvement in treatment decisions being crucial for optimal outcomes. Radiation and transoral robotic surgery offer similar ...
Intuitive Surgical introduced the da Vinci robotic-assisted surgery (RAS) system in 1998, and the FDA approved it for laparoscopic surgery in 2000. The da Vinci Xi was the advanced version of the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results